Ethical implications of dermatology reimbursement variations

Recent price transparency data have revealed wide variation in commercial insurer reimbursement for identical dermatologic services. Although some differences may reflect regional costs, institutional responsibilities, patient complexity, or broader health care infrastructure needs, unexplained variation raises ethical concerns about equity, access, justice, transparency, and sustainability. Reimbursement differences may reflect competing approaches to balancing health care costs, quality, public health priorities, and resource allocation; however, pricing advantages driven primarily by negotiating power rather than clinically meaningful standards risk undermining trust, access to care, and distributive justice. Supporting diverse practice models, particularly those serving rural and underserved populations, requires greater transparency, assessment of unexplained payment disparities, and reimbursement structures that better reflect clinical complexity, operational costs, and patient care needs. Finally, variability in insurance reimbursements can lead physicians to "game the system" to ensure their practices remain fiscally viable by dropping insurance networks that pay poorly. This disrupts the continuity of care for patients as well as the patient-physician bond and trust.